Institutional Ownership Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 44.4 Million shares, which have been reported (via 13F filing form) to have a value of $11.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
12,757,562
shares
|
$3.32 Million
1.67% of portfolio
|
Q2 2023
Added 39.48%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
4,339,101
shares
|
$1.13 Million
0.01% of portfolio
|
Q1 2024
Added 51.65%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
May 15, 2024 Q1 2024 |
2,820,982
shares
|
$733,455
1.13% of portfolio
|
Q1 2024
Reduced 30.35%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2024 Q1 2024 |
2,780,261
shares
|
$722,867
5.45% of portfolio
|
Q2 2023
Added 56.44%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2024 Q1 2024 |
2,742,460
shares
|
$713,039
0.04% of portfolio
|
Q1 2024
Reduced 8.58%
|
|
|
Vr Adviser, LLC
New York, NY |
May 15, 2024 Q1 2024 |
2,576,093
shares
|
$669,784
1.38% of portfolio
|
Q1 2024
Added 0.02%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
1,481,481
shares
|
$385,185
0.0% of portfolio
|
Q1 2024
Added 38.27%
|
|
|
Pura Vida Investments, LLC
New York, NY |
May 15, 2024 Q1 2024 |
1,413,242
shares
|
$367,442
6.26% of portfolio
|
Q2 2023
Reduced 29.23%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 16, 2024 Q1 2024 |
1,056,829
shares
|
$274,775
0.87% of portfolio
|
Q1 2024
Reduced 15.75%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
May 15, 2024 Q1 2024 |
1,003,741
shares
|
$260,972
5.49% of portfolio
|
Q1 2024
New holding
|
|
|
Tri Locum Partners LP
New York, NY |
May 15, 2024 Q1 2024 |
978,793
shares
|
$254,486
2.19% of portfolio
|
Q1 2024
New holding
|
|
|
Vestal Point Capital, LP
New York, NY |
May 13, 2024 Q1 2024 |
800,000
shares
|
$208,000
0.41% of portfolio
|
Q1 2024
Reduced 73.33%
|
|
|
Verition Fund Management LLC
Greenwich, CT |
May 14, 2024 Q1 2024 |
768,214
shares
|
$199,735
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
747,827
shares
|
$194,435
0.04% of portfolio
|
Q1 2024
Added 1662.75%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
676,554
shares
|
$175,904
0.04% of portfolio
|
Q1 2024
Added 12.76%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2024 Q1 2024 |
642,245
shares
|
$166,983
0.54% of portfolio
|
Q1 2024
Reduced 14.92%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2024 Q1 2024 |
591,311
shares
|
$153,740
0.01% of portfolio
|
Q1 2024
Added 96.1%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 14, 2024 Q1 2024 |
555,233
shares
|
$144,360
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 15, 2024 Q1 2024 |
528,118
shares
|
$137,310
0.01% of portfolio
|
Q1 2024
Added 3419.38%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
406,121
shares
|
$105,591
0.0% of portfolio
|
Q1 2024
Added 24.58%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
359,431
shares
|
$93,452
0.0% of portfolio
|
Q1 2024
Added 6.83%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
357,319
shares
|
$92,902
0.02% of portfolio
|
Q1 2024
Added 756.61%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
343,322
shares
|
$89,263
0.0% of portfolio
|
Q1 2024
Added 32.34%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
334,665
shares
|
$87,012
0.0% of portfolio
|
Q1 2024
Added 2461.93%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
250,000
shares
|
$65,000
0.01% of portfolio
|
Q1 2024
New holding
|
|